Literature DB >> 6248898

Intraventricular ACTH reduces social interaction in male rats.

S E File, A Clarke.   

Abstract

Intraventricular ACTH (1.25 microgram), ACTH (1.6 microgram) and ACTH:D-Phe (1.6 microgram) resulted in significant reductions in the time that pairs of male rats spent in active social interaction. This decrease in social behaviour was not accompanied by a decrease in motor activity. The results are similar to those previously found with peripheral administration of ACTH and suggest that these behavioural effects of ACTH are centrally mediated. None of the ACTH fragments had a significant effect on the latency with which thirsty rats started drinking in an unfamiliar environment. The results are discussed in relation to a possible anxiogenic action of ACTH.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6248898     DOI: 10.1016/0091-3057(80)90154-9

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  4 in total

1.  Antidepressant and anxiolytic profiles of newly synthesized arginine vasopressin V1B receptor antagonists: TASP0233278 and TASP0390325.

Authors:  M Iijima; T Yoshimizu; T Shimazaki; K Tokugawa; K Fukumoto; S Kurosu; T Kuwada; Y Sekiguchi; S Chaki
Journal:  Br J Pharmacol       Date:  2014-07       Impact factor: 8.739

2.  Physiologic characterization of novel aggressotropic neuropeptides.

Authors:  V V Sherstnev; N N Galeva; S A Kozyrev; V P Nikitin; M V Pletnikov; K V Sudakov; Z I Storozheva
Journal:  Neurosci Behav Physiol       Date:  1996 Sep-Dec

3.  Behavioural assays to model cognitive and affective dimensions of depression and anxiety in rats.

Authors:  M D S Lapiz-Bluhm; C O Bondi; J Doyen; G A Rodriguez; T Bédard-Arana; D A Morilak
Journal:  J Neuroendocrinol       Date:  2008-07-30       Impact factor: 3.627

4.  Antagonism of the anticonflict effects of chlordiazepoxide by beta-carboline carboxylic acid ethyl ester, Ro 15-1788 and ACTH(4--10).

Authors:  S V Vellucci; R A Webster
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.